Promega builds plant to produce regulated products
Including sample preparation systems and reagents
The 260,000ft2 (24,150m2) facility will require an additional 100 people in the next five years. Most of the building will be dedicated to fixed and flexible manufacturing areas. It will also house a customer experience centre for training, laboratory demonstrations and conferences.
‘This building is our next step in expanding our product supply capabilities worldwide,’ said ceo Bill Linton.
Plans include a number of sustainable practices, including geothermal heating and cooling, dark sky compliant lighting, prairie restoration, bio-retention ponds for storm water run off among other sustainable features and construction practices.
Promega Corporation provides solutions and technical support to the life sciences industry. Its 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification.
You may also like
Trending Articles
You may also like
Manufacturing
PCI Pharma Services commences installation of sterile fill-finish and lyophilisation line
The Bedford, NH site will advance PCI's manufacturing capabilities with twin lyophilisers and a large-scale isolator filling line, making this the third sterile fill-finish facility built in the last three years
Manufacturing
From batch to continuous chemistry to continuous processing
The main challenge in many flow reactors lies in achieving a smooth and continuous flow within microchannels. Dec Group focuses on effectively transporting solid materials and engineering the flow to enhance chemical processes and increase their efficiency
Manufacturing
High speed, high shear mixers for the pharmaceutical industry
From laboratory scale mixers capable of handling as little as 1 mL to production-scale models, including hygienic and ultra-hygienic mixing equipment specifically designed for pharmaceutical applications, Silverson Machines has a vast product range